Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients. Goyal, L., Saha, S. K, Liu, L. Y, Siravegna, G., Leshchiner, I., Ahronian, L. G, Lennerz, J. K, Vu, P., Mussolin, B., Reyes, S., & others Cancer Research, 77(13_Supplement):4114–4114, The American Association for Cancer Research, 2017.
bibtex   
@article{goyal2017polyclonal,
  title={Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients},
  author={Goyal, Lipika and Saha, Supriya K and Liu, Leah Y and Siravegna, Giulia and Leshchiner, Ignaty and Ahronian, Leanne G and Lennerz, Jochen K and Vu, Phuong and Mussolin, Benedetta and Reyes, Stephanie and others},
  journal={Cancer Research},
  volume={77},
  number={13\_Supplement},
  pages={4114--4114},
  year={2017},
  publisher={The American Association for Cancer Research}
}

Downloads: 0